Class Action Lawsuit for Investors in Agenus Inc.
If you're an investor in Agenus Inc., a well-known biotechnology company celebrated for its groundbreaking treatments, there's an important chance for you to get involved in a class action lawsuit. The action is spearheaded by Bronstein, Gewirtz & Grossman, LLC, a reputable law firm with expertise in securities fraud. They are dedicated to helping those who have faced significant financial losses while holding Agenus securities, particularly during the designated class period.
Eligibility and Class Definition
This class action lawsuit seeks to obtain compensation from the defendants for alleged violations of federal securities laws. It concerns all individuals and entities that bought or otherwise acquired shares of Agenus stock during specific periods. If you fall within that timeframe, you’re strongly encouraged to consider participating in the lawsuit.
What Are the Allegations?
The claims against the executives of the Company indicate that throughout the class period, they made materially false and misleading statements about the Company’s operations and its market potential. Specifically, the allegations state that the combination therapy involving botensilimab and balstilimab was not as effective as they had presented to investors. This misrepresentation is said to have artificially inflated the value of the stock during that time.
Steps for Investors Moving Forward
A class action has been set in motion, and if you’re looking to add your voice to this effort, you can find more information about the complaint on the law firm's official website. Investors who have experienced losses are urged to act promptly, as there's a deadline for requesting the court to recognize you as the lead plaintiff. However, remember that you don’t have to be the lead plaintiff to take part in the recovery process.
Understanding Cost Implications
It’s important to note that representation in class actions by Bronstein, Gewirtz & Grossman, LLC operates on a contingency basis. This means that the law firm will only collect legal fees and expenses if they win the case. This approach provides a way for investors to seek justice without having to pay upfront costs.
Why Choose Bronstein, Gewirtz & Grossman?
Bronstein, Gewirtz & Grossman, LLC is committed to assisting investors involved in cases of securities fraud and similar matters. With a proven track record of securing significant settlements for clients, they offer clear and dedicated representation. Their team is ready to help investors of Agenus Inc. navigate the challenges that come with this lawsuit.
How to Contact the Law Firm
If you have any questions or want to explore your options regarding the class action lawsuit, feel free to reach out to Peretz Bronstein or Nathan Miller at Bronstein, Gewirtz & Grossman, LLC. They are well-prepared to guide you through the legal process and address your concerns.
Frequently Asked Questions
What is the purpose of the class action lawsuit?
The class action lawsuit aims to seek damages for investors who have suffered losses due to misleading statements made by the executives of Agenus Inc.
Who is eligible to participate in the class action?
Individuals and entities that purchased or acquired Agenus securities during the specified class period are eligible to participate in the class action.
How can I join the class action lawsuit?
Interested investors should visit the law firm’s official website for instructions on how to join the lawsuit and obtain any necessary documents.
What are the costs associated with joining the class action?
Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, meaning you will not incur any costs unless there is successful recovery from the lawsuit.
Who should I contact for more information?
For further assistance, you can contact Peretz Bronstein or Nathan Miller from Bronstein, Gewirtz & Grossman, LLC to discuss your case and options.
